Navigation Links
How to prevent disparities in colon cancer screening
Date:6/16/2014

SEATTLEPeople living in poverty are less likely to be screened regularly for colorectal cancerand more likely to develop the disease and die from it. How to end these disparitiesand raise screening rates, lower disease rates, and prevent deaths? A promising way is to mail fecal immunochemical tests (a newer kind of stool test) to populations, Beverly B. Green, MD, MPH, and Gloria D. Coronado, PhD, wrote in the June 17 JAMA Internal Medicine.

Dr. Green is a Group Health physician and an associate investigator at Group Health Research Institute. Dr. Coronado is a senior investigator and the Mitch Greenlick endowed scientist for health disparities at Kaiser Permanente Center for Health Research, in Portland. The journal invited them to write a commentary about a study that David W. Baker, MD, MPH, of Northwestern University led and published in the same issue of the journal.

Drs. Green and Coronado applauded Baker's study for achieving repeat screening rates of more than 82 percent in a largely low-income community. But they were disappointed that only 60 percent of individuals with a positive screening stool test completed follow-up diagnostic colonoscopy. "Lack of a follow-up colonoscopy defeats the purpose of a stool-test screening program," said Dr. Green, who is also an assistant clinical professor at the University of Washington School of Medicine.

Previous studies have shown that when low-income people get colorectal cancer screening, they tend to prefer the option of doing a stool test in the privacy of their own home. But when the test is "positive" (detecting microscopic blood in the stool), people need to get a second test: a follow-up diagnostic colonoscopy. After a positive stool test, nearly a third of people have advanced pre-cancers that can be removed during the follow-up colonoscopyand 4 percent have colorectal cancer.

"For many people, the barriers to receiving the needed follow-up diagnostic colonoscopy include cost," Dr. Green said. For instance, the Affordable Care Act (ACA) mandates full coverage of screening tests that the U.S. Preventive Services Task Force (USPSTF) recommendswith no out-of-pocket expenses. But it covers only the first test that a person choosesa stool test, colonoscopy, or sigmoidoscopynot any follow-up diagnostic testing. That's why Drs. Green and Coronado previously urged that the ACA be amended to cover co-pays for follow-up colonoscopies after a positive stool test or flexible sigmoidoscopy. Otherwise, people who choose those as their first tests could face high, unexpected costs from follow-up testingand existing disparities in screening could worsen.

"On the other hand, most states' Medicaid insurance pays for both stool testing and follow-up colonoscopy, with no out-of-pocket patient costs," Dr. Coronado said. "So disparities in deaths from colorectal cancer could decrease rapidly in those states that have opted into Medicaid expansion."

Dr. Green previously showed in a randomized trial that colorectal cancer screening doubled when Group Health's electronic health record was used in a new way to identify people who needed screening and give them stepped increases in support. And Drs. Green and Coronado showed it was feasible to use a population-based program for mailing stool tests to people in safety-net clinics.


'/>"/>

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute
Source:Eurekalert  

Related medicine news :

1. UTMB to participate in $30 million national study to prevent falls in older people
2. Antiviral therapy may prevent liver cancer in hepatitis B patients
3. Disinfection caps successful in CLABSI prevention
4. Fatty liver disease prevented in mice
5. Opioid overdose prevention programs may reduce deaths, reports Journal of Addiction Medicine
6. New amyloid-reducing compound could be a preventive measure against Alzheimers
7. Screening has prevented half a million colorectal cancers
8. Surgeons report fewer postoperative blood clots using risk-based preventive measures
9. Diet and exercise in cancer prevention and treatment: Focus of APNM special
10. UC Davis and Orbis partner in telemedicine initiative to treat, prevent blindness
11. Temple-led study finds no benefit in taking statin drugs for COPD exacerbation prevention
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How to prevent disparities in colon cancer screening
(Date:5/27/2017)... ... , ... In any business, follow up is critical to success. It is ... presenting treatment, there will always be some patients who can’t or won’t make a ... practices when it comes to presenting treatment. After the patient leaves, most practices ...
(Date:5/26/2017)... YORK, NY (PRWEB) , ... May 26, 2017 ... ... Board (SAB) met this week to review more than eighty-nine grant submissions ... experienced and emerging young scientists in the Parkinson’s field.     , The American Parkinson ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the Congressional Budget Office (CBO) ... House on May 4, would result in 23 million Americans losing their health insurance ... 2010 Patient Protection and Affordable Care Act (ACA). , “It is clear from ...
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public using ... Viewers can reconnect with America as it explores some of the best places to ... for an inventive new place for a family vacation, and have discovered hiking. Many ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading healthcare data analytics ... 2017 ranking of the Best-Equipped Hospitals in Latin America ... GHI,s hospitals database for Latin America , which is ... database covers 86% of the hospitals in Latin ... each institution in key areas such as beds, medical specialties, ...
(Date:5/10/2017)... , May 10, 2017 CSSi, the ... for the clinical research industry, is proud to announce ... . The new website features both enriched content and ... experience and enhances the company,s already well-established position as ... "After many months of hard work, ...
(Date:5/9/2017)... May 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of ... Canadian Intellectual Property Office has granted Oramed a ... of Exenatide". The patent covers Oramed,s invention of ... GLP-1 is an incretin hormone that stimulates the ...
Breaking Medicine Technology: